Changes in Salivary Parameters of Oral Immunity after Biologic Therapy for Inflammatory Bowel Disease

Changes in Salivary Parameters of Oral Immunity after Biologic Therapy for Inflammatory Bowel Disease

We previously observed that inflammatory bowel disease (IBD) may compromise oral host defense, as assessed by decreased salivary levels of immunoglobulin A (IgA) and myeloperoxidase (MPO). Biologic therapy with inhibitors of cytokines or adhesion molecules is increasingly used for patients with IBD....

Full description

Bibliographic Details
Main Authors: Kacper Nijakowski, Rafał Rutkowski, Piotr Eder, Katarzyna Korybalska, Janusz Witowski, Anna Surdacka
Format: Article
Language:English
Published: MDPI AG 2021-12-01
Series:Life
Subjects:
inflammatory bowel disease
biologic therapy
saliva
biomarkers
myeloperoxidase
immunoglobulin A
Online Access:https://www.mdpi.com/2075-1729/11/12/1409

Internet

https://www.mdpi.com/2075-1729/11/12/1409

Similar Items